Nebenwirkungen · Actos
Actos 15 mg tablets Actos 30 mg tablets Actos 45 mg tablets · Abschnitt 4.8 · PDF-Seite 9
HOS-091043 · Präparat HOS-084177
Mono- with with with with insulin therapy metformin sulpho- metformin nylurea and sulpho- nylurea Musculoskeletal and connective tissue disorders fracture bone4 common common common common common arthralgia common common common back pain common Renal and urinary disorders haematuria common glycosuria uncommon proteinuria uncommon Reproductive system and breast disorders erectile dysfunction common General disorders and administration site conditions Oedema5 very common fatigue uncommon Investigations weight increased6 common common common common common blood creatine common phospho-kinase increased increased lactic uncommon dehydro-genase alanine not known not known not known not known not known aminotransferase increased7
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-08-28T15:56:00Z · SHA-256 9db485a8edb528eab1b3fb65eee070f4e61e0143333341420cf15c5240029983 · Passage 38db151cbeeb065b7599bab845b3fad7b7a5e925305b06aee87e82b370ae1e60 · Zeichen 3947–5760 im Abschnitt